Last reviewed · How we verify
NCT04038177
Superset Strength Training for Time-efficiency
NA trial testing Superset strength training in Sedentary Lifestyle in 30 participants. Completed in 20 December 2019.
20 December 2019
Quick facts
| Lead sponsor | Norwegian University of Science and Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 5 August 2019 |
| Primary completion | 20 December 2019 |
| Estimated completion | 20 December 2019 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Superset strength training
- Traditional strength training
Conditions studied
- Sedentary Lifestyle — all drugs for Sedentary Lifestyle →
Sponsor
Norwegian University of Science and Technology
Who can join
Adults 18 to 45, any sex, with Sedentary Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical inactivity is a global challenge and there is an urgent need to find strategies to increases people's activity levels. Strength training is one of the activities that is recommended to engage in regularly by both the American College of Sports Medicine and the World Health Organization. Understanding how strength training can be done effectively without spending much time could potentially increase people's involvement in strength training, as lack of time often is reported as barrier to training. Superset strength training can potentially be a time-efficient way of strength training, as this training method has been found to take half the time of the traditional ways of training. The aim of the present study is therefore to compare the effects of superset strength training and traditional strength training on muscular strength, body composition and fatigue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04038177
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sedentary Lifestyle
Currently open trials in the same condition.
- NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
- NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting
Other Norwegian University of Science and Technology trials
Trials by the same sponsor.
- NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
- NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
- NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
- NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
- NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04038177 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
- Last refreshed: 7 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038177.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing